The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ciclesonide Market Research Report 2025
Synopsis
Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada.
The global Ciclesonide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ciclesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ciclesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ciclesonide in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ciclesonide include Covis Pharma. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ciclesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ciclesonide.
Report Scope
The Ciclesonide market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ciclesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ciclesonide companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Covis Pharma
Segment by Type
Inhalation Aerosol 37 mcg/actuation
Inhalation Aerosol 80 mcg/actuation
Inhalation Aerosol 120 mcg/actuation
Inhalation Aerosol 160 mcg/actuation
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ciclesonide companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada.
The global Ciclesonide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Ciclesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ciclesonide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Ciclesonide in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Ciclesonide include Covis Pharma. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ciclesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ciclesonide.
Report Scope
The Ciclesonide market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ciclesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ciclesonide companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Covis Pharma
Segment by Type
Inhalation Aerosol 37 mcg/actuation
Inhalation Aerosol 80 mcg/actuation
Inhalation Aerosol 120 mcg/actuation
Inhalation Aerosol 160 mcg/actuation
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ciclesonide companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ciclesonide Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Inhalation Aerosol 37 mcg/actuation
1.2.3 Inhalation Aerosol 80 mcg/actuation
1.2.4 Inhalation Aerosol 120 mcg/actuation
1.2.5 Inhalation Aerosol 160 mcg/actuation
1.3 Market by Application
1.3.1 Global Ciclesonide Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ciclesonide Market Perspective (2019-2030)
2.2 Ciclesonide Growth Trends by Region
2.2.1 Global Ciclesonide Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Ciclesonide Historic Market Size by Region (2019-2024)
2.2.3 Ciclesonide Forecasted Market Size by Region (2025-2030)
2.3 Ciclesonide Market Dynamics
2.3.1 Ciclesonide Industry Trends
2.3.2 Ciclesonide Market Drivers
2.3.3 Ciclesonide Market Challenges
2.3.4 Ciclesonide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ciclesonide Players by Revenue
3.1.1 Global Top Ciclesonide Players by Revenue (2019-2024)
3.1.2 Global Ciclesonide Revenue Market Share by Players (2019-2024)
3.2 Global Ciclesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ciclesonide Revenue
3.4 Global Ciclesonide Market Concentration Ratio
3.4.1 Global Ciclesonide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ciclesonide Revenue in 2023
3.5 Ciclesonide Key Players Head office and Area Served
3.6 Key Players Ciclesonide Product Solution and Service
3.7 Date of Enter into Ciclesonide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ciclesonide Breakdown Data by Type
4.1 Global Ciclesonide Historic Market Size by Type (2019-2024)
4.2 Global Ciclesonide Forecasted Market Size by Type (2025-2030)
5 Ciclesonide Breakdown Data by Application
5.1 Global Ciclesonide Historic Market Size by Application (2019-2024)
5.2 Global Ciclesonide Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Ciclesonide Market Size (2019-2030)
6.2 North America Ciclesonide Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Ciclesonide Market Size by Country (2019-2024)
6.4 North America Ciclesonide Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ciclesonide Market Size (2019-2030)
7.2 Europe Ciclesonide Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Ciclesonide Market Size by Country (2019-2024)
7.4 Europe Ciclesonide Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ciclesonide Market Size (2019-2030)
8.2 Asia-Pacific Ciclesonide Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Ciclesonide Market Size by Region (2019-2024)
8.4 Asia-Pacific Ciclesonide Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ciclesonide Market Size (2019-2030)
9.2 Latin America Ciclesonide Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Ciclesonide Market Size by Country (2019-2024)
9.4 Latin America Ciclesonide Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ciclesonide Market Size (2019-2030)
10.2 Middle East & Africa Ciclesonide Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Ciclesonide Market Size by Country (2019-2024)
10.4 Middle East & Africa Ciclesonide Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Covis Pharma
11.1.1 Covis Pharma Company Detail
11.1.2 Covis Pharma Business Overview
11.1.3 Covis Pharma Ciclesonide Introduction
11.1.4 Covis Pharma Revenue in Ciclesonide Business (2019-2024)
11.1.5 Covis Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Ciclesonide Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Inhalation Aerosol 37 mcg/actuation
Table 3. Key Players of Inhalation Aerosol 80 mcg/actuation
Table 4. Key Players of Inhalation Aerosol 120 mcg/actuation
Table 5. Key Players of Inhalation Aerosol 160 mcg/actuation
Table 6. Global Ciclesonide Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Ciclesonide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Ciclesonide Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Ciclesonide Market Share by Region (2019-2024)
Table 10. Global Ciclesonide Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Ciclesonide Market Share by Region (2025-2030)
Table 12. Ciclesonide Market Trends
Table 13. Ciclesonide Market Drivers
Table 14. Ciclesonide Market Challenges
Table 15. Ciclesonide Market Restraints
Table 16. Global Ciclesonide Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Ciclesonide Market Share by Players (2019-2024)
Table 18. Global Top Ciclesonide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ciclesonide as of 2023)
Table 19. Ranking of Global Top Ciclesonide Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Ciclesonide Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Ciclesonide Product Solution and Service
Table 23. Date of Enter into Ciclesonide Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ciclesonide Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Ciclesonide Revenue Market Share by Type (2019-2024)
Table 27. Global Ciclesonide Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Ciclesonide Revenue Market Share by Type (2025-2030)
Table 29. Global Ciclesonide Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Ciclesonide Revenue Market Share by Application (2019-2024)
Table 31. Global Ciclesonide Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Ciclesonide Revenue Market Share by Application (2025-2030)
Table 33. North America Ciclesonide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Ciclesonide Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Ciclesonide Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Ciclesonide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Ciclesonide Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Ciclesonide Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Ciclesonide Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Ciclesonide Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Ciclesonide Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Ciclesonide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Ciclesonide Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Ciclesonide Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Ciclesonide Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Ciclesonide Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Ciclesonide Market Size by Country (2025-2030) & (US$ Million)
Table 48. Covis Pharma Company Detail
Table 49. Covis Pharma Business Overview
Table 50. Covis Pharma Ciclesonide Product
Table 51. Covis Pharma Revenue in Ciclesonide Business (2019-2024) & (US$ Million)
Table 52. Covis Pharma Recent Development
Table 53. Research Programs/Design for This Report
Table 54. Key Data Information from Secondary Sources
Table 55. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ciclesonide Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Ciclesonide Market Share by Type: 2023 VS 2030
Figure 3. Inhalation Aerosol 37 mcg/actuation Features
Figure 4. Inhalation Aerosol 80 mcg/actuation Features
Figure 5. Inhalation Aerosol 120 mcg/actuation Features
Figure 6. Inhalation Aerosol 160 mcg/actuation Features
Figure 7. Global Ciclesonide Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Ciclesonide Market Share by Application: 2023 VS 2030
Figure 9. Adults Case Studies
Figure 10. Children Case Studies
Figure 11. Ciclesonide Report Years Considered
Figure 12. Global Ciclesonide Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Ciclesonide Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Ciclesonide Market Share by Region: 2023 VS 2030
Figure 15. Global Ciclesonide Market Share by Players in 2023
Figure 16. Global Top Ciclesonide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ciclesonide as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Ciclesonide Revenue in 2023
Figure 18. North America Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Ciclesonide Market Share by Country (2019-2030)
Figure 20. United States Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Ciclesonide Market Share by Country (2019-2030)
Figure 24. Germany Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Ciclesonide Market Share by Region (2019-2030)
Figure 32. China Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Ciclesonide Market Share by Country (2019-2030)
Figure 40. Mexico Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Ciclesonide Market Share by Country (2019-2030)
Figure 44. Turkey Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Ciclesonide Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Covis Pharma Revenue Growth Rate in Ciclesonide Business (2019-2024)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
